Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer [NA]
This trial studies whether personalized education and genetic counseling can increase genetic testing uptake in patients with a known family…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Study of Multiparametric Ultrasound Imaging Methods [NA]
A clinical trial updating the status of a study on multiparametric ultrasound imaging methods, sponsored by Memorial Sloan Kettering Cancer …
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating Claudin 18.2-targeted CAR-T cells in unresectable/locally advanced or metastatic gastric, gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics [NA]
A clinical trial update for the HOPE-Genomics intervention aimed at improving cancer patients' knowledge of genomics, with results posted on…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Intravital Microscopy in Human Solid Tumors [NA]
Mayo Clinic is conducting a clinical trial using intravital microscopy in multiple solid tumors, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab combined with nab-paclitaxel and gemcitabine for perioperative treatment of high-risk resectab…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma [Phase 1, Phase 2]
Clinical trial update for VMD-928 as a monotherapy and in combination with pembrolizumab to treat TrkA overexpression-driven solid tumors or…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) [EARLY_Phase 1]
Early-phase Phase 1 study evaluating GC101 Tumor-Infiltrating Lymphocytes for advanced hepatobiliary and pancreatic cancers, currently recru…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer [NA]
This clinical trial update presents completed results on different patterns of target delineation in SBRT for locally advanced pancreatic ca…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating irinotecan hydrochloride liposome injection (II) in combination with oxaliplatin and 5-FU/Leucovorin versus AG as f…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement [NA]
This registry entry outlines a trial evaluating electron beam intraoperative radiation therapy following chemoradiation in pancreatic cancer…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
A clinical trial update describes the development of a predictive model to forecast immunotherapy response in non-resectable pancreatic canc…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer [NA]
A clinical trial entry describing the Alpha DaRT diffusing alpha-emitters radiation therapy device for locally advanced or unresectable panc…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Adebrelimab and Chidamide for Pancreatic Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating Adebrelimab in combination with Chidamide for pancreatic cancer, which is currentl…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer [NA]
This update describes a feasibility and safety study of intratumoral diffusing alpha radiation emitters for advanced pancreatic cancer. The …
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating the combination of gemcitabine and nab-paclitaxel with radiation t…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating YL-13027 in combination with gemcitabine and Nab-paclitaxel in patients with refractory metastatic pancreatic cance…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update describes a head-to-head Phase 2/3 study comparing NABPLAGEM to Nab-Paclitaxel plus Gemcitabine in patients with advan…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer [Phase 1]
Phase 1 trial evaluating the combination of guadecitabine and durvalumab in advanced cholangiocarcinoma, gallbladder cancer, hepatocellular …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Florida Pancreas Collaborative Next Generation Biobank
This clinical trial entry updates the Florida Pancreas Collaborative Next Generation Biobank (NCT03851133) sponsored by H. Lee Moffitt Cance…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
A clinical trial conducted by H. Lee Moffitt Cancer Center is investigating radiogenomics to predict the malignant potential of intraductal …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer [NA]
Feasibility study evaluating auricular acupressure for appetite and weight in patients with stage II–IV gastric, esophageal, or pancreatic c…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer [Phase 3]
Phase III trial update planning to compare the investigational GFH375 against standard chemotherapy in KRAS G12D-mutant metastatic pancreati…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating NC410 with FOLFIRINOX, with or without nivolumab and ipilimumab, for untreated metastatic pancreatic cancer; recrui…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas [Phase 2]
A Phase 2 platform study evaluating neoadjuvant and adjuvant immunotherapy for patients with resectable pancreatic adenocarcinoma; the trial…